SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Net Debt

Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Net Debt · Q1 FY2026 · quarter ended Mar 2026

Net debt of -$237.3M in Q1 FY2026

Q1 FY2026 net debt was -$237.3M.

Context

  • Net debt amounted to 91.8% of total assets at the end of Q1 FY2026.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$237.3M-150.4% QoQ
Last fiscal yearDec 2025
-$94.78M— YoY
Net Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Net Debt history

USD · from the balance sheet

Latest · FY2025
(94.78M) USD
Year-over-year change
—

Net Debt vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so net debt is compared through growth and share of total assets rather than absolute size.
  • Net debt amounts to 91.8% of total assets for SGP, versus a peer median of 21.0%.
SGP Competitors
Net Debt for SGP and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
BLCOBausch + Lomb CorporationJun 2026$4.75B USD+1.3%+31.9%34.3%
ALCAlcon Inc.Sep 2026$3.63B USD-3.0%-3.1%11.6%
RXSTRxSight, Inc.Mar 2026-$6.75M USD+57.7%—2.2%
GKOSGlaukos CorporationJun 2026-$11.65M USD-376.7%-43.0%1.3%
SGHTSight Sciences, Inc.Mar 2026-$43.2M USD+36.8%—39.4%
EYPTEyePoint Pharmaceuticals, Inc.Mar 2026-$57.48M USD+5.9%—19.9%
OCSOculis Holding AGMar 2026-CHF 62.13M CHF-5.7%—25.5%
STAASTAAR Surgical CompanyApr 2026-$94.57M USD+30.7%—21.0%
SGPSpyGlass Pharma, Inc. Common StockMar 2026-$237.3M USD——91.8%
OCULOcular Therapeutix, Inc.Mar 2026-$587.24M USD-114.7%—80.2%
Peer median (excluding SGP) —+1.3%-3.1%21.0%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.